Patienterne bør monitoreres omhyggeligt for bivirkninger og/ eller manglende effekt ved samtidig administration af voriconazol og REYATAZ / ritonavir.
Patients should be carefully monitored for adverse events and/ or loss of efficacy during the co-administration of voriconazole and REYATAZ/ ritonavir.